Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

Our Products
Overview
Partnering Search
Company Profiling
Partneringtools
Reports
Partnering Consulting
Comparison
 
Forums
Visit our forums
 
Jobs
Visit our job site
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire New!
 
Contact us
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing Ltd
is a division of
UTEK Corporation
Events

Calendar

The event diary contains full event literature for featured conferences - to get your conference or seminar featured, mail our sales staff.

Event details

view events from SMi Ltd Pharmaceutical Portfolio & Product Life Cycle Management
2 Jul 2008-3 Jul 2008 — London, United Kingdom (SMi Ltd)

SMi's 3rd Pharmaceutical Portfolio & Product Lifecycle Management conference will be held on Wednesday 2nd and Thursday 3rd July, 2008, in central London. This conference offers a unique opportunity to hear about the latest developments in Portfolio & Product Life Cycle Management from industry leaders.

Full literature available here

For more information contact:
Alia Malick
email: amalick@smi-online.co.uk
phone: +44 20 7827 6000
view events from Pharmalicensing 1335
16 Jul 2008-15 Jul 2008 — 1321321 (Pharmalicensing)
sldnfbfa,nfdn a,mwn faq,.

For more information contact:
email: mps@pharmalicensing.com
phone: +44 1904 520460
(other events from Pharmalicensing)
BioBusiness Asia 2008
22 Jul 2008-23 Jul 2008 — Taipei, Taiwan (DIGITIMES Inc.)
The BioBusiness Asia Conference is one of the most influential biotech events in the Asia Pacific Region.

For more information contact:
Ms. Sophia Lin
email: yuchien@itri.org.tw
phone: +886-2-8712-8866
Are Orphan Diseases an Entry Point to Larger Markets?
23 Jul 2008-30 Jul 2008 — Webinar (Decision Resources Inc.)

This presentation is based on our Orphan Disease Series reports. Orphan drug status can offer companies a number of unique advantages for their agents, particularly as competition increases in larger disease states and the hurdles to gaining regulatory approval increase.

 

Full literature available here

For more information contact:
Alison Fautré
email: afautre@decisionresources.be
phone: +32 2 357 06 15
(other events from Decision Resources Inc.)

Industry news: Pharmalicensing provides comprehensive industry coverage.

© Copyright 1995-2008 Pharmalicensing Ltd, is a division of UTEK Corporation All rights reserved. Terms and Conditions | Site map | Contact us